New pediatric cancer drug shows promising results for Austin boy
A new cancer treatment for children recently approved by the Food and Drug Administration is just the third pediatric cancer drug OK’d in two decades, and some of the trials happened in Austin. Rex Ryan, 3, participated in the clinical trial for the drug called Unituxin, which treats neuroblastoma — a type of cancer in the nerve cells. It usually appears in children 5 years old and younger.